Lyomark Pharma is a contract and active ingredient manufacturer. They supply sterile lyophilised (freeze-dried) and liquid products and their main product is a surfactant called Alveofact. Alveofact is commonly used to save premature babies by reducing inflammatory reactions in their underdeveloped lungs. 

By implementing EXTEDOpulse, Lyomark Pharma transformed its regulatory information management. The solution streamlined key processes such as Master Data Management, Registration Management, Submission Management, and Document Management. This enabled the company to take control of its data, automate updates, and bring submissions in-house, resulting in faster regulatory processes and reduced manual errors.

Download the case study now and learn more about how Lyomark benefits from using EXTEDOpulse. 

Fill out the form to download the free case study